共 45 条
- [21] Immunogenicity of GI-4000 vaccine in adjuvant consolidation therapy following definitive treatment in patients with stage I-III adenocarcinoma of the lung with G12C, G12D, or G12V KRAS mutationsJOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)D'Angelo, S. P.论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, New York, NY 10021 USAPark, B. J.论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, New York, NY 10021 USAKrug, L. M.论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, New York, NY 10021 USACrevar, C.论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, New York, NY 10021 USAMedina, C. E.论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, New York, NY 10021 USASumner, D. K.论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, New York, NY 10021 USARichman, J.论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, New York, NY 10021 USACoeshott, C.论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, New York, NY 10021 USAApelian, D.论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, New York, NY 10021 USACohn, A.论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, New York, NY 10021 USAKris, M. G.论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, New York, NY 10021 USAAzzoli, C. G.论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
- [22] Phase 2 Study of GI-4000 Vaccine as Adjuvant Consolidation Therapy Following Resection of Patients With Stage I-III Adenocarcinoma of the Lung With G12C, G12D, and G12V KRAS MutationsJOURNAL OF THORACIC ONCOLOGY, 2010, 5 (12) : S504 - S504D'Angelo, S. P.论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA Mem Sloan Kettering Canc Ctr, New York, NY 10021 USAPark, B.论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA Mem Sloan Kettering Canc Ctr, New York, NY 10021 USAKrug, L.论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA Mem Sloan Kettering Canc Ctr, New York, NY 10021 USACrevar, C.论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA Mem Sloan Kettering Canc Ctr, New York, NY 10021 USAMedina, C.论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA Mem Sloan Kettering Canc Ctr, New York, NY 10021 USASumner, D.论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA Mem Sloan Kettering Canc Ctr, New York, NY 10021 USARichman, J.论文数: 0 引用数: 0 h-index: 0机构: Globeimmune Inc, Louisville, CO USA Mem Sloan Kettering Canc Ctr, New York, NY 10021 USACohn, A.论文数: 0 引用数: 0 h-index: 0机构: Globeimmune Inc, Louisville, CO USA Mem Sloan Kettering Canc Ctr, New York, NY 10021 USAKris, M.论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA Mem Sloan Kettering Canc Ctr, New York, NY 10021 USAAzzoli, C. G.论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
- [23] ALTA3263: an oral, KRAS isoform-selective, dual ON/OFF state, non-covalent inhibitor induces regressions across KRAS G12V, G12D, and G12C cancer modelsEUROPEAN JOURNAL OF CANCER, 2024, 211 : S5 - S6Wang, T.论文数: 0 引用数: 0 h-index: 0机构: Alterome Therapeut Inc, Discovery Biol, San Diego, CA USA Alterome Therapeut Inc, Discovery Biol, San Diego, CA USAIbanez, M.论文数: 0 引用数: 0 h-index: 0机构: Alterome Therapeut Inc, Discovery Biol, San Diego, CA USA Alterome Therapeut Inc, Discovery Biol, San Diego, CA USAYu, K.论文数: 0 引用数: 0 h-index: 0机构: Alterome Therapeut Inc, Discovery Biol, San Diego, CA USA Alterome Therapeut Inc, Discovery Biol, San Diego, CA USAFan, K.论文数: 0 引用数: 0 h-index: 0机构: Alterome Therapeut Inc, Discovery Biol, San Diego, CA USA Alterome Therapeut Inc, Discovery Biol, San Diego, CA USAJuan, J.论文数: 0 引用数: 0 h-index: 0机构: Alterome Therapeut Inc, Discovery Biol, San Diego, CA USA Alterome Therapeut Inc, Discovery Biol, San Diego, CA USAPerez, M.论文数: 0 引用数: 0 h-index: 0机构: Alterome Therapeut Inc, Discovery Biol, San Diego, CA USA Alterome Therapeut Inc, Discovery Biol, San Diego, CA USASmith, T.论文数: 0 引用数: 0 h-index: 0机构: Alterome Therapeut Inc, Discovery Biol, San Diego, CA USA Alterome Therapeut Inc, Discovery Biol, San Diego, CA USAWalsh, B.论文数: 0 引用数: 0 h-index: 0机构: Alterome Therapeut Inc, Discovery Biol, San Diego, CA USA Alterome Therapeut Inc, Discovery Biol, San Diego, CA USAKang, V.论文数: 0 引用数: 0 h-index: 0机构: Alterome Therapeut Inc, Discovery Biol, San Diego, CA USA Alterome Therapeut Inc, Discovery Biol, San Diego, CA USATyhonas, J.论文数: 0 引用数: 0 h-index: 0机构: Alterome Therapeut Inc, Discovery Biol, San Diego, CA USA Alterome Therapeut Inc, Discovery Biol, San Diego, CA USAAlvarez, N.论文数: 0 引用数: 0 h-index: 0机构: Alterome Therapeut Inc, Discovery Biol, San Diego, CA USA Alterome Therapeut Inc, Discovery Biol, San Diego, CA USATran, J.论文数: 0 引用数: 0 h-index: 0机构: Alterome Therapeut Inc, Discovery Biol, San Diego, CA USA Alterome Therapeut Inc, Discovery Biol, San Diego, CA USAMoorefield, K. S.论文数: 0 引用数: 0 h-index: 0机构: Alterome Therapeut Inc, Discovery Biol, San Diego, CA USA Alterome Therapeut Inc, Discovery Biol, San Diego, CA USAPhimister, A.论文数: 0 引用数: 0 h-index: 0机构: Alterome Therapeut Inc, Discovery Biol, San Diego, CA USA Alterome Therapeut Inc, Discovery Biol, San Diego, CA USAZhu, X.论文数: 0 引用数: 0 h-index: 0机构: Alterome Therapeut Inc, Discovery Biol, San Diego, CA USA Alterome Therapeut Inc, Discovery Biol, San Diego, CA USAChi, A.论文数: 0 引用数: 0 h-index: 0机构: Alterome Therapeut Inc, Discovery Biol, San Diego, CA USA Alterome Therapeut Inc, Discovery Biol, San Diego, CA USABartberger, M. D.论文数: 0 引用数: 0 h-index: 0机构: Alterome Therapeut Inc, Discovery Biol, San Diego, CA USA Alterome Therapeut Inc, Discovery Biol, San Diego, CA USAMurphy, E.论文数: 0 引用数: 0 h-index: 0机构: Alterome Therapeut Inc, Discovery Biol, San Diego, CA USA Alterome Therapeut Inc, Discovery Biol, San Diego, CA USA
- [24] Phase II Study of the GI-4000 KRAS Vaccine After Curative Therapy in Patients With Stage I-III Lung Adenocarcinoma Harboring a KRAS G12C, G12D, or G12V MutationCLINICAL LUNG CANCER, 2014, 15 (06) : 405 - 410Chaft, Jamie E.论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, Dept Med, Div Solid Tumor Oncol, Thorac Oncol Serv, New York, NY 10065 USA Weill Cornell Med Coll, New York, NY USA Mem Sloan Kettering Canc Ctr, Dept Med, Div Solid Tumor Oncol, Thorac Oncol Serv, New York, NY 10065 USALitvak, Anya论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, Dept Med, Div Solid Tumor Oncol, Thorac Oncol Serv, New York, NY 10065 USA Weill Cornell Med Coll, New York, NY USA Mem Sloan Kettering Canc Ctr, Dept Med, Div Solid Tumor Oncol, Thorac Oncol Serv, New York, NY 10065 USAArcila, Maria E.论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, Dept Pathol, Diagnost Mol Pathol Serv, New York, NY 10021 USA Mem Sloan Kettering Canc Ctr, Dept Med, Div Solid Tumor Oncol, Thorac Oncol Serv, New York, NY 10065 USAPatel, Payal论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, Dept Med, Div Solid Tumor Oncol, Thorac Oncol Serv, New York, NY 10065 USA Weill Cornell Med Coll, New York, NY USA Mem Sloan Kettering Canc Ctr, Dept Med, Div Solid Tumor Oncol, Thorac Oncol Serv, New York, NY 10065 USAD'Angelo, Sandra P.论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, Dept Med, Div Solid Tumor Oncol, Thorac Oncol Serv, New York, NY 10065 USA Weill Cornell Med Coll, New York, NY USA Mem Sloan Kettering Canc Ctr, Dept Med, Div Solid Tumor Oncol, Thorac Oncol Serv, New York, NY 10065 USAKrug, Lee M.论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, Dept Med, Div Solid Tumor Oncol, Thorac Oncol Serv, New York, NY 10065 USA Weill Cornell Med Coll, New York, NY USA Mem Sloan Kettering Canc Ctr, Dept Med, Div Solid Tumor Oncol, Thorac Oncol Serv, New York, NY 10065 USARusch, Valerie论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, Dept Surg, New York, NY 10021 USA Mem Sloan Kettering Canc Ctr, Dept Med, Div Solid Tumor Oncol, Thorac Oncol Serv, New York, NY 10065 USAMattson, Alicia论文数: 0 引用数: 0 h-index: 0机构: GlobeImmune Inc, Louisville, CO USA Mem Sloan Kettering Canc Ctr, Dept Med, Div Solid Tumor Oncol, Thorac Oncol Serv, New York, NY 10065 USACoeshott, Claire论文数: 0 引用数: 0 h-index: 0机构: GlobeImmune Inc, Louisville, CO USA Mem Sloan Kettering Canc Ctr, Dept Med, Div Solid Tumor Oncol, Thorac Oncol Serv, New York, NY 10065 USAPark, Bernard论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, Dept Surg, New York, NY 10021 USA Mem Sloan Kettering Canc Ctr, Dept Med, Div Solid Tumor Oncol, Thorac Oncol Serv, New York, NY 10065 USAApelian, David M.论文数: 0 引用数: 0 h-index: 0机构: GlobeImmune Inc, Louisville, CO USA Mem Sloan Kettering Canc Ctr, Dept Med, Div Solid Tumor Oncol, Thorac Oncol Serv, New York, NY 10065 USAKris, Mark G.论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, Dept Med, Div Solid Tumor Oncol, Thorac Oncol Serv, New York, NY 10065 USA Weill Cornell Med Coll, New York, NY USA Mem Sloan Kettering Canc Ctr, Dept Med, Div Solid Tumor Oncol, Thorac Oncol Serv, New York, NY 10065 USAAzzoli, Christopher G.论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, Dept Med, Div Solid Tumor Oncol, Thorac Oncol Serv, New York, NY 10065 USA Weill Cornell Med Coll, New York, NY USA Mem Sloan Kettering Canc Ctr, Dept Med, Div Solid Tumor Oncol, Thorac Oncol Serv, New York, NY 10065 USA
- [25] AMPLIFY-7P: Phase 1 and randomized phase 2 study of amphiphile immunotherapy ELI-002 7P as adjuvant treatment for subjects with G12D, G12R, G12V, G12C, G12A, G12S and G13D Kirsten rat sarcoma (KRAS)-mutated pancreatic ductal adenocarcinoma.JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (3_SUPPL) : TPS720 - TPS720Wainberg, Zev A.论文数: 0 引用数: 0 h-index: 0机构: Univ Calif Los Angeles, Sch Med, Los Angeles, CA USAChung, Vincent论文数: 0 引用数: 0 h-index: 0机构: Univ Calif Los Angeles, Sch Med, Los Angeles, CA USADevoe, Craig E.论文数: 0 引用数: 0 h-index: 0机构: Univ Calif Los Angeles, Sch Med, Los Angeles, CA USAGeorge, Thomas J.论文数: 0 引用数: 0 h-index: 0机构: Univ Calif Los Angeles, Sch Med, Los Angeles, CA USAWelkowsky, Esther论文数: 0 引用数: 0 h-index: 0机构: Univ Calif Los Angeles, Sch Med, Los Angeles, CA USAKheoh, Thian论文数: 0 引用数: 0 h-index: 0机构: Univ Calif Los Angeles, Sch Med, Los Angeles, CA USAHaqq, Christopher M.论文数: 0 引用数: 0 h-index: 0机构: Univ Calif Los Angeles, Sch Med, Los Angeles, CA USAPant, Shubham论文数: 0 引用数: 0 h-index: 0机构: Univ Calif Los Angeles, Sch Med, Los Angeles, CA USAO'Reilly, Eileen Mary论文数: 0 引用数: 0 h-index: 0机构: Univ Calif Los Angeles, Sch Med, Los Angeles, CA USA
- [26] Crystal Structure of a Human K-Ras G12D Mutant in Complex with GDP and the Cyclic Inhibitory Peptide KRpep-2dACS MEDICINAL CHEMISTRY LETTERS, 2017, 8 (07): : 732 - 736Sogabe, Satoshi论文数: 0 引用数: 0 h-index: 0机构: Takeda Pharmaceut Co Ltd, Div Pharmaceut Res, 26-1,Muraoka Higashi 2 Chome, Fujisawa, Kanagawa 2518555, Japan Takeda Pharmaceut Co Ltd, Div Pharmaceut Res, 26-1,Muraoka Higashi 2 Chome, Fujisawa, Kanagawa 2518555, JapanKamada, Yusuke论文数: 0 引用数: 0 h-index: 0机构: Takeda Pharmaceut Co Ltd, Div Pharmaceut Res, 26-1,Muraoka Higashi 2 Chome, Fujisawa, Kanagawa 2518555, Japan Takeda Pharmaceut Co Ltd, Div Pharmaceut Res, 26-1,Muraoka Higashi 2 Chome, Fujisawa, Kanagawa 2518555, JapanMiwa, Masanori论文数: 0 引用数: 0 h-index: 0机构: Takeda Pharmaceut Co Ltd, Div Pharmaceut Res, 26-1,Muraoka Higashi 2 Chome, Fujisawa, Kanagawa 2518555, Japan Takeda Pharmaceut Co Ltd, Div Pharmaceut Res, 26-1,Muraoka Higashi 2 Chome, Fujisawa, Kanagawa 2518555, JapanNiida, Ayumu论文数: 0 引用数: 0 h-index: 0机构: Takeda Pharmaceut Co Ltd, Div Pharmaceut Res, 26-1,Muraoka Higashi 2 Chome, Fujisawa, Kanagawa 2518555, Japan SCOHIA PHARMA Inc, 2-26-1 Muraokahigashi, Fujisawa, Kanagawa 2518555, Japan Takeda Pharmaceut Co Ltd, Div Pharmaceut Res, 26-1,Muraoka Higashi 2 Chome, Fujisawa, Kanagawa 2518555, JapanSameshima, Tomoya论文数: 0 引用数: 0 h-index: 0机构: Takeda Pharmaceut Co Ltd, Div Pharmaceut Res, 26-1,Muraoka Higashi 2 Chome, Fujisawa, Kanagawa 2518555, Japan Takeda Pharmaceut Co Ltd, Div Pharmaceut Res, 26-1,Muraoka Higashi 2 Chome, Fujisawa, Kanagawa 2518555, JapanKamaura, Masahiro论文数: 0 引用数: 0 h-index: 0机构: Takeda Pharmaceut Co Ltd, Div Pharmaceut Res, 26-1,Muraoka Higashi 2 Chome, Fujisawa, Kanagawa 2518555, Japan Takeda Pharmaceut Co Ltd, Div Pharmaceut Res, 26-1,Muraoka Higashi 2 Chome, Fujisawa, Kanagawa 2518555, JapanYonemori, Kazuko论文数: 0 引用数: 0 h-index: 0机构: Takeda Pharmaceut Co Ltd, Div Pharmaceut Res, 26-1,Muraoka Higashi 2 Chome, Fujisawa, Kanagawa 2518555, Japan Takeda Pharmaceut Co Ltd, Div Pharmaceut Res, 26-1,Muraoka Higashi 2 Chome, Fujisawa, Kanagawa 2518555, JapanSasaki, Shigekazu论文数: 0 引用数: 0 h-index: 0机构: Takeda Pharmaceut Co Ltd, Div Pharmaceut Res, 26-1,Muraoka Higashi 2 Chome, Fujisawa, Kanagawa 2518555, Japan Takeda Pharmaceut Co Ltd, Div Pharmaceut Res, 26-1,Muraoka Higashi 2 Chome, Fujisawa, Kanagawa 2518555, JapanSakamoto, Jun-ichi论文数: 0 引用数: 0 h-index: 0机构: Takeda Pharmaceut Co Ltd, Div Pharmaceut Res, 26-1,Muraoka Higashi 2 Chome, Fujisawa, Kanagawa 2518555, Japan Takeda Pharmaceut Co Ltd, Div Pharmaceut Res, 26-1,Muraoka Higashi 2 Chome, Fujisawa, Kanagawa 2518555, JapanSakamoto, Kotaro论文数: 0 引用数: 0 h-index: 0机构: Takeda Pharmaceut Co Ltd, Div Pharmaceut Res, 26-1,Muraoka Higashi 2 Chome, Fujisawa, Kanagawa 2518555, Japan Ichimaru Pharcos Co Ltd, 318-1 Asagi Motosu Shi, Gifu 5010475, Japan Takeda Pharmaceut Co Ltd, Div Pharmaceut Res, 26-1,Muraoka Higashi 2 Chome, Fujisawa, Kanagawa 2518555, Japan
- [27] In silico-guided sequence modifications of K-ras epitopes improve immunological outcome against G12V and G13D mutant KRAS antigensPEERJ, 2018, 6Ng, Allan Wee Ren论文数: 0 引用数: 0 h-index: 0机构: UCSI Univ, Fac Appl Sci, Dept Biotechnol, Kuala Lumpur, Malaysia UCSI Univ, Fac Appl Sci, Dept Biotechnol, Kuala Lumpur, MalaysiaTan, Pei Jun论文数: 0 引用数: 0 h-index: 0机构: UCSI Univ, Fac Appl Sci, Dept Biotechnol, Kuala Lumpur, Malaysia UCSI Univ, Fac Appl Sci, Dept Biotechnol, Kuala Lumpur, MalaysiaHoo, Winfrey Pui Yee论文数: 0 引用数: 0 h-index: 0机构: UCSI Univ, Fac Appl Sci, Dept Biotechnol, Kuala Lumpur, Malaysia UCSI Univ, Fac Appl Sci, Dept Biotechnol, Kuala Lumpur, MalaysiaLiew, Dek Shen论文数: 0 引用数: 0 h-index: 0机构: UCSI Univ, Fac Appl Sci, Dept Biotechnol, Kuala Lumpur, Malaysia UCSI Univ, Fac Appl Sci, Dept Biotechnol, Kuala Lumpur, MalaysiaTeo, Michelle Yee Mun论文数: 0 引用数: 0 h-index: 0机构: UCSI Univ, Fac Appl Sci, Dept Biotechnol, Kuala Lumpur, Malaysia UCSI Univ, Fac Appl Sci, Dept Biotechnol, Kuala Lumpur, MalaysiaSiak, Pui Yan论文数: 0 引用数: 0 h-index: 0机构: UCSI Univ, Fac Appl Sci, Dept Biotechnol, Kuala Lumpur, Malaysia UCSI Univ, Fac Appl Sci, Dept Biotechnol, Kuala Lumpur, MalaysiaNg, Sze Man论文数: 0 引用数: 0 h-index: 0机构: UCSI Univ, Fac Appl Sci, Dept Biotechnol, Kuala Lumpur, Malaysia UCSI Univ, Fac Appl Sci, Dept Biotechnol, Kuala Lumpur, MalaysiaTan, Ee Wern论文数: 0 引用数: 0 h-index: 0机构: UCSI Univ, Fac Appl Sci, Dept Biotechnol, Kuala Lumpur, Malaysia UCSI Univ, Fac Appl Sci, Dept Biotechnol, Kuala Lumpur, MalaysiaRahim, Raha Abdul论文数: 0 引用数: 0 h-index: 0机构: Univ Putra Malaysia, Fac Biotechnol & Biomol Sci, Dept Cell & Mol Biol, Upm Serdang, Selangor, Malaysia UCSI Univ, Fac Appl Sci, Dept Biotechnol, Kuala Lumpur, MalaysiaLim, Renee Lay Hong论文数: 0 引用数: 0 h-index: 0机构: UCSI Univ, Fac Appl Sci, Dept Biotechnol, Kuala Lumpur, Malaysia UCSI Univ, Fac Appl Sci, Dept Biotechnol, Kuala Lumpur, MalaysiaSong, Adelene Ai Lian论文数: 0 引用数: 0 h-index: 0机构: Univ Putra Malaysia, Fac Biotechnol & Biomol Sci, Dept Microbiol, Upm Serdang, Selangor, Malaysia UCSI Univ, Fac Appl Sci, Dept Biotechnol, Kuala Lumpur, MalaysiaIn, Lionel Lian Aun论文数: 0 引用数: 0 h-index: 0机构: UCSI Univ, Fac Appl Sci, Dept Biotechnol, Kuala Lumpur, Malaysia UCSI Univ, Fac Appl Sci, Dept Biotechnol, Kuala Lumpur, Malaysia
- [28] Retrospective comparative analysis of K-ras G12C vs other K-ras mutations in metastatic colorectal cancer patients treated with first-line chemotherapy doublet plus bevacizumabANNALS OF ONCOLOGY, 2021, 32 : S200 - S200Giampieri, R.论文数: 0 引用数: 0 h-index: 0机构: Univ Politecn Marche, Clin Oncol, Azienda Osped Univ Osped Riuniti Umberto I GM Lan, Ancona, Italy Univ Politecn Marche, Clin Oncol, Azienda Osped Univ Osped Riuniti Umberto I GM Lan, Ancona, ItalyLupi, A.论文数: 0 引用数: 0 h-index: 0机构: Univ Politecn Marche, Clin Oncol, Azienda Osped Univ Osped Riuniti Umberto I GM Lan, Ancona, Italy Univ Politecn Marche, Clin Oncol, Azienda Osped Univ Osped Riuniti Umberto I GM Lan, Ancona, Italy论文数: 引用数: h-index:机构:Pecci, F.论文数: 0 引用数: 0 h-index: 0机构: Univ Politecn Marche, Clin Oncol, Azienda Osped Univ Osped Riuniti Umberto I GM Lan, Ancona, Italy Univ Politecn Marche, Clin Oncol, Azienda Osped Univ Osped Riuniti Umberto I GM Lan, Ancona, Italy论文数: 引用数: h-index:机构:Persano, M.论文数: 0 引用数: 0 h-index: 0机构: Univ Hosp, Med Oncol Unit, Monserrato, Italy Univ Cagliari, Monserrato, Italy Univ Politecn Marche, Clin Oncol, Azienda Osped Univ Osped Riuniti Umberto I GM Lan, Ancona, ItalyCrocetti, S.论文数: 0 引用数: 0 h-index: 0机构: Univ Politecn Marche, Clin Oncol, Azienda Osped Univ Osped Riuniti Umberto I GM Lan, Ancona, Italy Univ Politecn Marche, Clin Oncol, Azienda Osped Univ Osped Riuniti Umberto I GM Lan, Ancona, ItalyGiglio, E.论文数: 0 引用数: 0 h-index: 0机构: Univ Politecn Marche, Clin Oncol, Azienda Osped Univ Osped Riuniti Umberto I GM Lan, Ancona, Italy Univ Politecn Marche, Clin Oncol, Azienda Osped Univ Osped Riuniti Umberto I GM Lan, Ancona, ItalyBittoni, A.论文数: 0 引用数: 0 h-index: 0机构: Univ Politecn Marche, Clin Oncol, Azienda Osped Univ Osped Riuniti Umberto I GM Lan, Ancona, Italy Univ Politecn Marche, Clin Oncol, Azienda Osped Univ Osped Riuniti Umberto I GM Lan, Ancona, ItalyMandolesi, A.论文数: 0 引用数: 0 h-index: 0机构: Univ Politecn Marche, Anat Patol, Azienda Osped Univ Osped Riuniti Umberto I GM Lan, Ancona, Italy Univ Politecn Marche, Clin Oncol, Azienda Osped Univ Osped Riuniti Umberto I GM Lan, Ancona, ItalyScartozzi, M.论文数: 0 引用数: 0 h-index: 0机构: Univ Hosp, Med Oncol Unit, Monserrato, Italy Univ Cagliari, Monserrato, Italy Univ Politecn Marche, Clin Oncol, Azienda Osped Univ Osped Riuniti Umberto I GM Lan, Ancona, ItalyBerardi, R.论文数: 0 引用数: 0 h-index: 0机构: Univ Politecn Marche, Clin Oncol, Azienda Osped Univ Osped Riuniti Umberto I GM Lan, Ancona, Italy Univ Politecn Marche, Clin Oncol, Azienda Osped Univ Osped Riuniti Umberto I GM Lan, Ancona, Italy
- [29] Crystal structures of the state 1 conformations of the GTP-bound H-Ras protein and its oncogenic G12V and Q61L mutantsFEBS LETTERS, 2012, 586 (12) : 1715 - 1718Muraoka, Shin论文数: 0 引用数: 0 h-index: 0机构: Kobe Univ, Grad Sch Med, Dept Biochem & Mol Biol, Div Mol Biol,Chuo Ku, Kobe, Hyogo 6500017, Japan Kobe Univ, Grad Sch Med, Dept Biochem & Mol Biol, Div Mol Biol,Chuo Ku, Kobe, Hyogo 6500017, JapanShima, Fumi论文数: 0 引用数: 0 h-index: 0机构: Kobe Univ, Grad Sch Med, Dept Biochem & Mol Biol, Div Mol Biol,Chuo Ku, Kobe, Hyogo 6500017, Japan Kobe Univ, Grad Sch Med, Dept Biochem & Mol Biol, Div Mol Biol,Chuo Ku, Kobe, Hyogo 6500017, JapanAraki, Mitsugu论文数: 0 引用数: 0 h-index: 0机构: Kobe Univ, Grad Sch Sci, Dept Chem, Nada Ku, Kobe, Hyogo 6578501, Japan Kobe Univ, Grad Sch Med, Dept Biochem & Mol Biol, Div Mol Biol,Chuo Ku, Kobe, Hyogo 6500017, JapanInoue, Tomoko论文数: 0 引用数: 0 h-index: 0机构: Kobe Univ, Grad Sch Med, Dept Biochem & Mol Biol, Div Mol Biol,Chuo Ku, Kobe, Hyogo 6500017, Japan Kobe Univ, Grad Sch Med, Dept Biochem & Mol Biol, Div Mol Biol,Chuo Ku, Kobe, Hyogo 6500017, JapanYoshimoto, Akiko论文数: 0 引用数: 0 h-index: 0机构: Kobe Univ, Grad Sch Med, Dept Biochem & Mol Biol, Div Mol Biol,Chuo Ku, Kobe, Hyogo 6500017, Japan Kobe Univ, Grad Sch Med, Dept Biochem & Mol Biol, Div Mol Biol,Chuo Ku, Kobe, Hyogo 6500017, JapanIjiri, Yuichi论文数: 0 引用数: 0 h-index: 0机构: Kobe Univ, Grad Sch Med, Dept Biochem & Mol Biol, Div Mol Biol,Chuo Ku, Kobe, Hyogo 6500017, Japan Kobe Univ, Grad Sch Med, Dept Biochem & Mol Biol, Div Mol Biol,Chuo Ku, Kobe, Hyogo 6500017, JapanSeki, Nobuaki论文数: 0 引用数: 0 h-index: 0机构: Kobe Univ, Grad Sch Sci, Dept Chem, Nada Ku, Kobe, Hyogo 6578501, Japan Kobe Univ, Grad Sch Med, Dept Biochem & Mol Biol, Div Mol Biol,Chuo Ku, Kobe, Hyogo 6500017, JapanTamura, Atsuo论文数: 0 引用数: 0 h-index: 0机构: Kobe Univ, Grad Sch Sci, Dept Chem, Nada Ku, Kobe, Hyogo 6578501, Japan Kobe Univ, Grad Sch Med, Dept Biochem & Mol Biol, Div Mol Biol,Chuo Ku, Kobe, Hyogo 6500017, JapanKumasaka, Takashi论文数: 0 引用数: 0 h-index: 0机构: JASRI, Sayo, Hyogo 6795198, Japan Kobe Univ, Grad Sch Med, Dept Biochem & Mol Biol, Div Mol Biol,Chuo Ku, Kobe, Hyogo 6500017, JapanYamamoto, Masaki论文数: 0 引用数: 0 h-index: 0机构: RIKEN SPring 8 Ctr, Sayo, Hyogo 6795148, Japan Kobe Univ, Grad Sch Med, Dept Biochem & Mol Biol, Div Mol Biol,Chuo Ku, Kobe, Hyogo 6500017, JapanKataoka, Tohru论文数: 0 引用数: 0 h-index: 0机构: Kobe Univ, Grad Sch Med, Dept Biochem & Mol Biol, Div Mol Biol,Chuo Ku, Kobe, Hyogo 6500017, Japan Kobe Univ, Grad Sch Med, Dept Biochem & Mol Biol, Div Mol Biol,Chuo Ku, Kobe, Hyogo 6500017, Japan
- [30] A phase 1 study of D3S-001, a second-generation GDP-bound KRAS G12C inhibitor, as monotherapy in patients with KRAS G12C-mutated solid tumorsCANCER RESEARCH, 2024, 84 (07)Cho, Byoung Chul论文数: 0 引用数: 0 h-index: 0Lu, Shun论文数: 0 引用数: 0 h-index: 0Lee, Myung Ah论文数: 0 引用数: 0 h-index: 0Song, Zhengbo论文数: 0 引用数: 0 h-index: 0Park, John论文数: 0 引用数: 0 h-index: 0Lim, Sun Min论文数: 0 引用数: 0 h-index: 0Li, Ziming论文数: 0 引用数: 0 h-index: 0Zhao, Jun论文数: 0 引用数: 0 h-index: 0Richardson, Gary论文数: 0 引用数: 0 h-index: 0Zhang, Yanqiao论文数: 0 引用数: 0 h-index: 0Zhang, Jun论文数: 0 引用数: 0 h-index: 0Liu, Anwen论文数: 0 引用数: 0 h-index: 0Chen, Cheng论文数: 0 引用数: 0 h-index: 0Wang, Jia论文数: 0 引用数: 0 h-index: 0Lu, Jingtao论文数: 0 引用数: 0 h-index: 0Rui, Haopeng论文数: 0 引用数: 0 h-index: 0Chen, Qian论文数: 0 引用数: 0 h-index: 0Wang, Hui论文数: 0 引用数: 0 h-index: 0Zhang, Jing论文数: 0 引用数: 0 h-index: 0Chen, Zhi Jian论文数: 0 引用数: 0 h-index: 0Mok, Tony论文数: 0 引用数: 0 h-index: 0